Posted by Two Blokes
Despite a Q2 EPS miss and higher credit loss allowances, I reiterate my buy rating on PEBO due to strong funda
Source: Two Blokes Trading
Posted by Two Blokes
HWM battles transportation market headwinds, but aerospace strength and F-35 orders help offset the drag.
Source: Two Blokes Trading
Posted by Two Blokes
HD's fiscal 2025 inventory strategy, bolstered by SRS and smart seasonal planning, is driving stronger product
Source: Two Blokes Trading
Posted by Two Blokes
AXON's drone push gains traction with Skydio, Dedrone deals and rising public safety demand fueling future gro
Source: Two Blokes Trading
Posted by Two Blokes
TD Bank Group's TD Merchant Solutions will use payments and financial technology from Fiserv, including the po
Source: Two Blokes Trading
Posted by Two Blokes
The U.K.'s Competition and Markets Authority (CMA) announced on Wednesday a proposal that would give Apple and
Source: Two Blokes Trading
Posted by Two Blokes
Pre-Markets in Green Amid Trade Deal With Japan.
Source: Two Blokes Trading
Posted by Two Blokes
Reblozyl sales surged 35% in Q1 for BMY, but a failed phase III study clouds expansion plans amid stiff anemia
Source: Two Blokes Trading
Posted by Two Blokes
EXEL investors eye Cabometyx sales and zanzalintinib trial results ahead of Q2 earnings release on July 28.
Source: Two Blokes Trading
Posted by Two Blokes
Most AI stocks at the moment are at nosebleed valuations.
Source: Two Blokes Trading
Posted by Two Blokes
DARZALEX Faspro\u00ae is co-formulated with Halozyme's ENHANZE\u00ae drug delivery technology Approval represe
Source: Two Blokes Trading
Posted by Two Blokes
CPRX, STKL, GAMB and ORN are gaining attention as rising cash flows signal strength, flexibility and growth po
Source: Two Blokes Trading